
Hangzhou Tigermed Consulting Co., Ltd.
Depository Receipt · US41044T1088 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Hangzhou Tigermed Consulting Co., Ltd.
No Price
Closing Price OTC 28.04.2026:
4,00 USD
28.04.2026 20:00
Current Prices from Hangzhou Tigermed Consulting Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
HNGZY
|
USD
|
28.04.2026 20:00
|
4,00 USD
| 0,00 USD |
Company Profile for Hangzhou Tigermed Consulting Co., Ltd. Depository Receipt
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Company Data
Name Hangzhou Tigermed Consulting Co., Ltd.
Company Hangzhou Tigermed Consulting Co., Ltd.
Website
https://www.tigermed.net
Primary Exchange
UTC
ISIN US41044T1088
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Xiaoping Ye D.Phil, EMBA,
Market Capitalization 6 Mrd.
Country China
Currency USD
Employees 10,2 T
Address F18, Building A – Shengda Science Park, 310051 Hangzhou
IPO Date 2022-07-11
Dividends from 'Hangzhou Tigermed Consulting Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 13.06.2025 | 0,04 USD |
| 11.06.2024 | 0,08 USD |
| 25.05.2023 | 0,08 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | HNGZY |
More Shares
Investors who hold Hangzhou Tigermed Consulting Co., Ltd. also have the following shares in their portfolio:

